Orphan Drug Act of 1983

• The original aim is to help the companies to develop drugs when no reasonable expectation exists that the costs of developing and distributing these drugs will be recovered from the sales of the drugs

Previous slide

Next slide

Back to first slide

View graphic version

A cross-national comparison of oprhan drug policies: Implications for the U.S. Orphan Drug Act Journal of Health Politics, Policy and Law; Durham; Apr 1998; Mae Thamer; Niall Brennan; Rafael Semansky;